BudgetSensors, a Bulgarian manufacturer of silicon and silicon nitride probes, as well as AFM accessories for Atomic Force Microscopes (AFM), announces the introduction of a new tapping mode AFM probe, as well as a new feature for a selection of AFM probes.
Nanogen, Inc., developer of advanced diagnostic products, announced today that the Company plans to close commercial operations of the array business and reduce staff by approximately 20%. Today‚??s announcement follows the decision in September to investigate strategic alternatives for the array business.
Nanophase Technologies, a technology leader in nanomaterials and advanced nanoengineered products, announced that Mr. George Vincent has been appointed as an independent director to Nanophase's board effective November 6, 2007.
Coronis Systems a provider of ultra-low power wireless OEM solutions for both short range and long range wireless sensor, control and metering networks and Essensium N.V., a fabless semiconductor provider of low power System-on-Chip ASIC solutions, today announced an agreement to collaborate on the next generation Wavenis technology transceiver chip.
According to a new technical market research report, Nanorobotics and NEMS, the global market for nanorobots and nanoelectromechanical systems (NEMS), and related materials and equipment, increased from $29.5 million in 2004 to $34.2 million in 2005, with sales reaching an estimated $40.3 million by the end of 2006. By 2011, the market will reach $830.4 million, a compound annual growth rate (CAGR) of 83.1%.
Alltracel Pharmaceuticals Plc. today announces that its Nanopeutics subsidiary has signed a collaborative technology development agreement with ConvaTec, a world-leading manufacturer of ostomy and wound care products.
Novel diagnostics focusing on the management of therapeutics, innovative nanoscale drug and vaccine delivery technology, pioneering use of small molecule therapeutic products for treating multiple diseases of the brain, cutting edge technology for the production of algae-based biofuels, new concepts for bio-prosthetic heart valves, and late-stage development and commercialization of gastroenterology products comprise the six finalists in this year's BioWest Venture Showcase competition.
Nanogen, Inc., developer of advanced diagnostic products, will host a conference call on Monday, November 12, 2007 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2007 third quarter financial results.
Michael Edelman, CEO of Nanoco Technologies presented some of the latest developments in the company s material at the Challenges in Organic Electronics conference at the Core Technology Facility in Manchester.